TickerGuard
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Cigna Corp (CI)

Healthcare Healthcare Plans
279.10 $
-3.0% vs. previous close
Closing price · As of: 31. Jul 2026
🔔 Watch stock

Stock Watch

Stock Watch will tell you what changes at Cigna Corp.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Appears in These Scanners

This stock currently matches 4 of our scanner strategies — each hit links to the scanner.

Quality & Balance Sheet
Dividends

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Trading Day

Previous Close
287.70$
Open
285.10$
Day High
287.40$
Day Low
279.00$
Volume
2,176,596shares

Key levels of the most recently completed trading day — not a live quote.

52-Week Range

52-Week Low 52-Week High
244.40 $ 311.00 $
10/31/2025 10/03/2025

Current price 279.10 $ — 52% of the range above the low.

Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.

Basics

Market Cap
73.6$B
Shares Outstanding
264Mio.
Float
99.5%
Beta
0.3

Performance

Perf. 1M
-1.40%
Perf. 3M
7.00%
Perf. 6M
2.60%
YTD Performance (%)
4.00%
52-Week-High Distance
-16.8%
Perf. 1Y
6.68%
Perf. 3Y
0.11%
Perf. 5Y
33.32%
Perf. 10Y
139.44%
Perf. Since Inception
19,463.24%

Technical Indicators

MA 38 Days
288.30$
MA 50 Days
286.50$
MA 200 Days
279.90$
RSI (14)
43.0
Volatility 30 Days
32.2%
Volatility 250 Days
33.2%

Calculated from the price history · as of 08/03/2026

Valuation

P/E
11.9
Forward P/E
9.2
PEG
0.8
P/B
1.8
P/S
0.3
EV/EBITDA
7.7
Price/FCF
7.8

Profitability

Gross Margin
9.1%
EBIT Margin
5.5%
Net Margin
2.3%
Return on Equity
16.3%
Return on Assets
4.5%

Balance Sheet & Safety

Equity Ratio
27.5%
negative equity
Debt/Equity
-9.3
Altman Z″
4.71
very solid
Piotroski
8 out of 9

Growth

Sales Growth Last Quarter
4.60%
EPS Growth Last Quarter
29.10%
Sales Growth (Year)
11.26%
Forward Sales Growth
4.43%
Forward EPS Growth
10.00%

Dividend

Dividend Yield
2.24%
Dividend Per Share (TTM)
6.14$
Payout Ratio
19.5%
Years Without a Cut
20Years
Increase Streak
5Years

Quality & Screener

Stage
3
RS Rating
38
EPS Rating
70
very solid
Piotroski
8 out of 9
Fundamental Rating
B (55 out of 100)
Altman Z″
4.71

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Analysts & Price Target

Current Price 279.10 $
Price Target (average) 343.38 $

The price target sits 23.0% above the current price.

Consensus
Sell
Analyst Ratings
25
Distribution of Recommendations
Strong Buy 13
Buy 6
Hold 6
Sell 0
Strong Sell 0

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
12/31/2026 30.48 30.37 – 30.58 285,968 2.2% 22
12/31/2027 33.51 32.42 – 34.26 298,232 9.9% 24

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 65,649.0 $M Q4 2025: Q1 · 65,502.0 $M Q1 2025: Q2 · 67,230.0 $M Q2 2025: Q3 · 69,748.0 $M Q3 2025: Q4 · 72,472.0 $M Q4 2026: Q1 · 68,494.0 $M Q1 2026: Q2 · 71,668.0 $M Q2

Source: fundamental data

Compare with other stocks →

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 5.13 46.70 65,649 28.40 2.20 5,212 4,875
2025: Q1 4.85 65,502 14.40 2.00 1,920 1,593
2025: Q2 5.71 4.80 67,230 11.10 2.30 -1,886 -2,171
2025: Q3 6.97 165.30 69,748 9.50 2.70 3,418 3,140
2025: Q4 4.64 -9.50 72,472 10.40 1.70 6,149 5,827
2026: Q1 6.26 29.10 68,494 4.60 2.40 1,131 864
2026: Q2 6.29 10.20 71,668 6.60 2.30 -421 -421
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Annual Figures

Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 39,838 3,088 1,867 7.19 4,026 13,723 59,360
2017 41,806 3,942 2,237 9.17 4,086 13,735 61,759
2018 48,650 4,160 2,637 10.69 3,770 41,028 153,226
2019 153,566 8,077 5,104 13.44 9,485 45,338 155,774
2020 160,401 8,153 8,458 22.96 10,350 50,321 155,451
2021 174,069 7,941 5,370 15.75 7,191 47,112 154,889
2022 180,518 8,450 6,704 21.41 8,656 44,872 143,885
2023 195,265 8,536 5,164 17.39 11,813 46,223 152,761
2024 247,121 9,417 3,434 12.12 10,363 41,033 155,881
2025 274,952 9,129 5,957 22.40 9,601 41,713 157,919

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

About the Company

The Cigna Group bietet mit ihren Tochtergesellschaften Versicherungs- und zugehörige Produkte und Dienste in den USA an. Es ist in zwei Segmenten tätig: Evernorth Health Services und Cigna Healthcare.

Employees65,669
HeadquartersBloomfield, CT
Address900 Cottage Grove Road, 06002 Bloomfield, United States
Phone860 226 6000
Websitethecignagroup.com
IPO Date31. Mar 1982
ISINUS1255231003
Stock Split3:1 on 06/05/2007

Management

Management
Name Title Birth Year
David Michael Cordani Executive Chairman of the Board 1965
Brian Case Evanko C.F.A. President, CEO & Director 1977
Ann M. Dennison Executive VP & CFO 1971
Nicole Susan Jones J.D. Executive Vice President, Chief Administrative Officer & Chief Human Resources Officer 1971
F. Everett Neville Executive VP & Special Advisor to the CEO 1965
Jamie Kates Senior VP & Tax and Global Chief Accounting Officer 1981
Durga Prasad Koka Executive Vice President & Global Chief Information Officer
Ralph Giacobbe Senior Vice President of Investor Relations
Andrea Nelson EVP, General Counsel & Corporate Secretary
Melissa Skottegaard Executive Vice President, Chief Marketing & Communications Officer

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Chart

Interactive price chart (TradingView).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?